EpiThany is dedicated to the advancement of innovative therapies that can improve the lives of cancer patients. Our focus is on developing tumor vaccines that drive Th1 (tumor-eradicating) immune responses without stimulating competitive Th2 (tumor-tolerant) responses.
Assets acquired by Aston in 2021
Assets acquired by Aston in 2021
Location: United States, District of Columbia, Washington